HOXA9 promotes hematopoietic commitment of human embryonic stem cells.

Abstract:

:The molecular determinants regulating the specification of human embryonic stem cells (hESCs) into hematopoietic cells remain elusive. HOXA9 plays a relevant role in leukemogenesis and hematopoiesis. It is highly expressed in hematopoietic stem and progenitor cells (HSPCs) and is downregulated upon differentiation. Hoxa9-deficient mice display impaired hematopoietic development, and deregulation of HOXA9 expression is frequently associated with acute leukemia. Analysis of the genes differentially expressed in cord blood HSPCs vs hESC-derived HSPCs identified HOXA9 as the most downregulated gene in hESC-derived HSPCs, suggesting that expression levels of HOXA9 may be crucial for hematopoietic differentiation of hESC. Here we show that during hematopoietic differentiation of hESCs, HOXA9 expression parallels hematopoietic development, but is restricted to the hemogenic precursors (HEP) (CD31(+)CD34(+)CD45(-)), and diminishes as HEPs differentiate into blood cells (CD45(+)). Different gain-of-function and loss-of-function studies reveal that HOXA9 enhances hematopoietic differentiation of hESCs by specifically promoting the commitment of HEPs into primitive and total CD45(+) blood cells. Gene expression analysis suggests that nuclear factor-κB signaling could be collaborating with HOXA9 to increase hematopoietic commitment. However, HOXA9 on its own is not sufficient to confer in vivo long-term engraftment potential to hESC-hematopoietic derivatives, reinforcing the idea that additional molecular regulators are needed for the generation of definitive in vivo functional HSPCs from hESC.

journal_name

Blood

journal_title

Blood

authors

Ramos-Mejía V,Navarro-Montero O,Ayllón V,Bueno C,Romero T,Real PJ,Menendez P

doi

10.1182/blood-2014-03-558825

subject

Has Abstract

pub_date

2014-11-13 00:00:00

pages

3065-75

issue

20

eissn

0006-4971

issn

1528-0020

pii

blood-2014-03-558825

journal_volume

124

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Critical role of class IA PI3K for c-Rel expression in B lymphocytes.

    abstract::The fact that the Xid mutation of Btk impairs the ability of pleckstrin homology domain of Btk to bind phosphatidylinositol-(3,4,5)-trisphosphate, a product of class IA phosphoinositide-3 kinases (PI3Ks), has been considered strong evidence for the hypothesis that Btk functions downstream of PI3Ks. We demonstrate here...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-163725

    authors: Matsuda S,Mikami Y,Ohtani M,Fujiwara M,Hirata Y,Minowa A,Terauchi Y,Kadowaki T,Koyasu S

    更新日期:2009-01-29 00:00:00

  • ALDH marks leukemia stem cell.

    abstract::In this issue of Blood,Gerber et al use aldehyde dehydrogenase (ALDH) activity to further subdivide the CD34(+)CD38(-) compartment in the bone marrow of acute myeloid leukemia (AML) patients. They identify a unique population with intermediate ALDH activity (ALDH(int)) that contains leukemia stem cells (LSCs). Moreove...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-02-406751

    authors: Fleischman AG

    更新日期:2012-04-12 00:00:00

  • Manipulating leukocyte interactions in vivo through optogenetic chemokine release.

    abstract::Light-mediated release of signaling ligands, such as chemoattractants, growth factors, and cytokines is an attractive strategy for investigation and therapeutic targeting of leukocyte communication and immune responses. We introduce a versatile optogenetic method to control ligand secretion, combining UV-conditioned e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-684852

    authors: Sarris M,Olekhnovitch R,Bousso P

    更新日期:2016-06-09 00:00:00

  • Altered expression of Pax-5 gene in human myeloma cells.

    abstract::Recent phenotypic analysis of plasma cells showed that normal plasma cells do express the B-cell lineage-specific molecule CD19, but their malignant counterpart (myeloma cells) are CD19-. To clarify the meaning of loss of CD19 antigen on myeloma cells, we first compared the expression of CD19 and Pax-5 genes among B c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mahmoud MS,Huang N,Nobuyoshi M,Lisukov IA,Tanaka H,Kawano MM

    更新日期:1996-05-15 00:00:00

  • Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.

    abstract::Myeloma plasma cells constitute 10% to 90% of the total bone marrow cell count in patients with multiple myeloma (MM). These cells express a variety of cell surface markers, such as HLA-ABC and HLA-DR, and surface antigens that are necessary for professional antigen-presenting cells, including adhesion and costimulato...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yi Q,Dabadghao S,Osterborg A,Bergenbrant S,Holm G

    更新日期:1997-09-01 00:00:00

  • Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

    abstract::Fibrin is essential for hemostasis; however, abnormal fibrin formation is hypothesized to increase thrombotic risk. We previously showed that in situ thrombin generation on a cell's surface modulates the 3-dimensional structure and stability of the fibrin network. Currently, we compared the abilities of extravascular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-228940

    authors: Campbell RA,Overmyer KA,Selzman CH,Sheridan BC,Wolberg AS

    更新日期:2009-11-26 00:00:00

  • CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects.

    abstract::Adoptive T-cell therapy using CD3/CD28 co-stimulation likely requires in vivo generation of antigen specificity. Because CD28 promotes TH1/TC1 (T1) or TH2/TC2 (T2) differentiation, costimulation may generate donor T1 or T2 cells capable of differentially mediating allogeneic graft-versus-tumor (GVT) effects and graft-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3936

    authors: Jung U,Foley JE,Erdmann AA,Eckhaus MA,Fowler DH

    更新日期:2003-11-01 00:00:00

  • CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

    abstract::The combination of cyclophosphamide, vincristine, and prednisone (CVP) is one of several standard treatment options for advanced follicular lymphoma. This, like similar chemotherapeutic regimens, induces response rates of 60% to 80%, with a median response duration of under 2 years. Rituximab, a chimeric monoclonal an...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2004-08-3175

    authors: Marcus R,Imrie K,Belch A,Cunningham D,Flores E,Catalano J,Solal-Celigny P,Offner F,Walewski J,Raposo J,Jack A,Smith P

    更新日期:2005-02-15 00:00:00

  • Hemopoietic lineage commitment decisions: in vivo evidence from a transgenic mouse model harboring micro LCR-betapro-LacZ as a transgene.

    abstract::A substantial body of published data suggests activation of lineage-specific genes in multipotential hemopoietic cells before their unilineage commitment. Because the behavior and plasticity of cells isolated in vitro away from microenvironmental constraints exercised in vivo may be altered, one wonders whether simila...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Papayannopoulou T,Priestley GV,Rohde A,Peterson KR,Nakamoto B

    更新日期:2000-02-15 00:00:00

  • Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.

    abstract::We examined the expression of messenger RNA (mRNA) of the human inducible nitric oxide synthase (hiNOS) gene in a panel of human T-cell lines. Reverse transcriptase-polymerase chain reaction showed that human T-cell leukemia virus type-I (HTLV-I)-infected T-cell lines (MT-1, SLB-1, and C5/MJ) expressed mRNA for the hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Nunokawa Y,Yamada Y,Ikeda S,Tomonaga M,Yamamoto N

    更新日期:1999-10-15 00:00:00

  • Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

    abstract::Acute myeloid leukemia (AML) is one of the most common acute leukemias in adults and children, yet significant numbers of patients relapse and die of disease. In this study, we identify the dependence of AML blasts on arginine for proliferation. We show that AML blasts constitutively express the arginine transporters ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-600643

    authors: Mussai F,Egan S,Higginbotham-Jones J,Perry T,Beggs A,Odintsova E,Loke J,Pratt G,U KP,Lo A,Ng M,Kearns P,Cheng P,De Santo C

    更新日期:2015-04-09 00:00:00

  • Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression.

    abstract::Inflammatory responses represent a hallmark of numerous pathologies including sepsis, bacterial infection, insulin resistance, and malign obesity. Here we describe an unexpected coactivator function for the nuclear receptor interacting protein 140 (RIP140) for nuclear factor kappaB (NFkappaB), a master transcriptional...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-11-121699

    authors: Zschiedrich I,Hardeland U,Krones-Herzig A,Berriel Diaz M,Vegiopoulos A,Müggenburg J,Sombroek D,Hofmann TG,Zawatzky R,Yu X,Gretz N,Christian M,White R,Parker MG,Herzig S

    更新日期:2008-07-15 00:00:00

  • Lymphokine(s) from isolated T lymphocyte subpopulations support multilineage hematopoietic colony and megakaryocytic colony formation.

    abstract::Conditioned medium derived from peripheral mononuclear low-density cells stimulated with phytohemagglutinin (PHA) supports the growth of noncommitted hematopoietic progenitors from marrow and peripheral blood cells. These immature progenitors (CFU-GEMM) can be identified in culture as multilineage hematopoietic coloni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kanz L,Löhr GW,Fauser AA

    更新日期:1986-11-01 00:00:00

  • CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.

    abstract::CTLA-4 is an inhibitory molecule that down-regulates T-cell activation. Although polymorphisms at CTLA-4 have been correlated with autoimmune diseases their association with clinical outcome after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has yet to be explored. A total of 5 CTLA-4 single-nucleoti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-069781

    authors: Pérez-García A,De la Cámara R,Román-Gómez J,Jiménez-Velasco A,Encuentra M,Nieto JB,de la Rubia J,Urbano-Ispizúa A,Brunet S,Iriondo A,González M,Serrano D,Espigado I,Solano C,Ribera JM,Pujal JM,Hoyos M,Gallardo D,GVHD\

    更新日期:2007-07-01 00:00:00

  • E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules.

    abstract::The selectins are lectin-like cell surface glycoproteins that have been implicated in playing a crucial role in the initiation of leukocyte adhesion to endothelial cells (ECs) during inflammation. Binding of selectins under conditions of flow mediates leukocyte rolling, which in vivo is almost exclusively observed in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Olofsson AM,Arfors KE,Ramezani L,Wolitzky BA,Butcher EC,von Andrian UH

    更新日期:1994-10-15 00:00:00

  • Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma.

    abstract::Plasma glutathione peroxidase (GSHPx) (glutathione: H2O2 oxidoreductase) is a unique selenoglycoprotein. Treatment of this enzyme with glycopeptidase F partially deglycosylates it and establishes the presence of N-linked sugar moieties. Antibodies raised in a rabbit against the purified enzyme from plasma were found t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Avissar N,Whitin JC,Allen PZ,Palmer IS,Cohen HJ

    更新日期:1989-01-01 00:00:00

  • Notes from the Director, National Heart, Lung, and Blood Institute: transitions.

    abstract::During this time of transition in the federal government and the National Institutes of Health, I write to assure the Blood community of the National Heart, Lung, and Blood Institute's (NHLBI) commitment to new and established investigators as outlined in the NHLBI Strategic Plan. This perspective discusses the NHLBI ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-194100

    authors: Nabel EG

    更新日期:2009-03-26 00:00:00

  • The EC domains of human fibrinogen420 contain calcium binding sites but lack polymerization pockets.

    abstract::The extended (E) isoform unique to Fibrinogen420 (Fib420) is distinguished from the conventional chain of Fibrinogen340 by the presence of an additional 236-residue carboxyl terminus globular domain (EC). A recombinant form of EC (rEC), having a predicted mass of 27,653 Daltons, was expressed in yeast (Pichia pastoris...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Applegate D,Haraga L,Hertzberg KM,Steben LS,Zhang JZ,Redman CM,Grieninger G

    更新日期:1998-11-15 00:00:00

  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

    abstract::Natural killer (NK) cells have held great promise for the immunotherapy of cancer for more than 3 decades. However, to date only modest clinical success has been achieved manipulating the NK cell compartment in patients with malignant disease. Progress in the field of NK cell receptors has revolutionized our concept o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-02-0350

    authors: Farag SS,Fehniger TA,Ruggeri L,Velardi A,Caligiuri MA

    更新日期:2002-09-15 00:00:00

  • Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

    abstract::Neutrophilic-chronic myeloid leukemia (CML-N) is a rare myeloproliferative disorder that runs a much more benign course than chronic myeloid leukemia, and for which no specific underlying molecular lesion has been described so far. We have analyzed the genomic DNA by Southern blotting and the BCR/ABL hybrid gene trans...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pane F,Frigeri F,Sindona M,Luciano L,Ferrara F,Cimino R,Meloni G,Saglio G,Salvatore F,Rotoli B

    更新日期:1996-10-01 00:00:00

  • Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.

    abstract::Complex molecular mechanisms control B-cell fate to become a memory or a plasma cell. Interleukin-24 (IL-24) is a class II family cytokine of poorly understood immune function that regulates the cell cycle. We previously observed that IL-24 is strongly expressed in leukemic memory-type B cells. Here we show that IL-24...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-220251

    authors: Maarof G,Bouchet-Delbos L,Gary-Gouy H,Durand-Gasselin I,Krzysiek R,Dalloul A

    更新日期:2010-03-04 00:00:00

  • Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses.

    abstract::The nuclear receptors (NR) retinoid X receptors (RXRs) exert immunomodulatory functions to control inflammation and metabolism via homodimers and heterodimers with several other NRs including retinoic acid receptors. IRX4204 is a novel, highly specific RXR agonist in clinical trials that potently and selectively activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005628

    authors: Thangavelu G,Wang C,Loschi M,Saha A,Osborn M,Furlan SN,Aoyama K,McDonald-Hyman C,Aguilar EG,Janesick AS,Chandraratna RA,Refaeli Y,Panoskaltsis-Mortari A,MacDonald KP,Hill GR,Zeiser R,Maillard I,Serody J,Murphy WJ,Mu

    更新日期:2020-09-24 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Thrombopoietin therapy increases platelet yields in healthy platelet donors.

    abstract::The recombinant thrombopoietins have been shown to be effective stimulators of platelet production in cancer patients. It was therefore of interest to determine if one of these, pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), could be used to increase platelet counts and conseque...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood.v98.5.1339

    authors: Kuter DJ,Goodnough LT,Romo J,DiPersio J,Peterson R,Tomita D,Sheridan W,McCullough J

    更新日期:2001-09-01 00:00:00

  • Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

    abstract::Marrow cells of myeloid lineage from 115 patients with myelodysplastic syndrome (MDS) were characterized by multidimensional flow cytometry and compared with findings in 104 patients with various disorders and 25 healthy donors. Based on phenotypic and scatter characteristics, a flow cytometric scoring system (FCSS) w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2768

    authors: Wells DA,Benesch M,Loken MR,Vallejo C,Myerson D,Leisenring WM,Deeg HJ

    更新日期:2003-07-01 00:00:00

  • Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

    abstract::Multiple myeloma (MM) is associated with severe normochromic/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the patho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1305

    authors: Silvestris F,Cafforio P,Tucci M,Dammacco F

    更新日期:2002-02-15 00:00:00

  • Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow.

    abstract::We have investigated the role of adenosine diphosphate (ADP) receptors in the adhesion, activation, and aggregation of platelets perfused over immobilized von Willebrand factor (VWF) under high shear stress. Blocking P2Y(1) prevented stable platelet adhesion and aggregation, indicative of a complete inhibition of alph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1145

    authors: Mazzucato M,Cozzi MR,Pradella P,Ruggeri ZM,De Marco L

    更新日期:2004-11-15 00:00:00

  • Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.

    abstract::Chronic myelomonocytic leukemia (CMML) is a hematological malignancy characterized by uncontrolled proliferation of dysplastic myelomonocytes and frequent progression to acute myeloid leukemia (AML). We identified mutations in the Cbl gene, which encodes a negative regulator of cytokine signaling, in a subset of CMML ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-724658

    authors: Nakata Y,Ueda T,Nagamachi A,Yamasaki N,Ikeda KI,Sera Y,Takubo K,Kanai A,Oda H,Sanada M,Ogawa S,Tsuji K,Ebihara Y,Wolff L,Honda ZI,Suda T,Inaba T,Honda H

    更新日期:2017-04-13 00:00:00

  • A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

    abstract::Ibrutinib is highly efficacious and used at 420 mg/d for treatment of chronic lymphocytic leukemia (CLL). We previously demonstrated a decline in Bruton's tyrosine kinase (BTK) protein levels in CLL cells after 1 cycle of ibrutinib, suggesting ibrutinib dose could be lowered after the first cycle without loss of biolo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2018-06-860593

    authors: Chen LS,Bose P,Cruz ND,Jiang Y,Wu Q,Thompson PA,Feng S,Kroll MH,Qiao W,Huang X,Jain N,Wierda WG,Keating MJ,Gandhi V

    更新日期:2018-11-22 00:00:00

  • FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation.

    abstract::Cytokine-induced expansion of hematopoietic stem and progenitor cells (HSPCs) is not fully understood. In the present study, we show that whereas steady-state hematopoiesis is normal in basic fibroblast growth factor (FGF-2)-knockout mice, parathyroid hormone stimulation and myeloablative treatments failed to induce n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-11-394692

    authors: Itkin T,Ludin A,Gradus B,Gur-Cohen S,Kalinkovich A,Schajnovitz A,Ovadya Y,Kollet O,Canaani J,Shezen E,Coffin DJ,Enikolopov GN,Berg T,Piacibello W,Hornstein E,Lapidot T

    更新日期:2012-08-30 00:00:00